Woori Venture Partners

Woori Venture Partners is a venture capital firm based in Seoul, South Korea, founded in 1981. As a subsidiary of Woori Financial Group, the firm focuses on investments across various sectors, including entertainment and content, mobility, chemicals, manufacturing, semiconductors, biotechnology and healthcare, consumer services, and software, including the metaverse. The firm actively seeks to support innovative startups and growth-stage companies within these industries, aiming to foster technological advancement and economic development.

Chihoon Hyun

Managing Director

34 past transactions

Surfin

Series A in 2025
Surfin is a financial services company focused on providing wealth management and risk management solutions through innovative fintech applications. The firm develops a financial management and risk control platform that leverages artificial intelligence algorithms to enhance user experiences. By analyzing user profiles and behaviors, Surfin's technology incorporates intelligent identification and liveness detection to identify fraudulent activities, thereby improving risk control efficiency. This approach not only helps clients mitigate financial risks but also safeguards users' personal data, ensuring a secure and reliable financial environment.

INTAKE foods

Series C in 2025
INTAKE foods is a company that specializes in food content development and branding, with a strong emphasis on innovation in the food industry. The company operates a food technology platform that aims to replace high-ecological-cost food resources with sustainable alternatives. It offers a diverse range of products made from Korean grains, vegetables, fruits, and nuts, including energy bars and coffee lines designed to provide essential vitamins and nutrients. This focus on healthy and sustainable food options enables consumers to enhance their well-being while supporting a culture of innovation in food consumption.

Wrtn Technologies

Series B in 2025
Wrtn Technologies develops an AI-based content creation platform that utilizes natural language processing to assist users in writing. Aimed at addressing the challenges associated with declining writing skills, the platform enables a collaborative approach where AI and humans work together. This innovative tool is designed particularly for Gen-Z, helping them enhance their creativity and productivity in writing. By leveraging advanced AI technology, Wrtn Technologies provides a unique solution that empowers clients to improve their writing capabilities and overcome obstacles in the creative process.
Xnergy Autonomous Power Technologies is a universal fast charging platform.

Carro

Venture Round in 2024
Carro is an automotive marketplace that offers a full-stack service for all aspects of car ownership. It challenges the traditional way of buying and selling of cars through a proprietary pricing algorithm. Carro also provides a range of services that offer everything a car owner needs throughout their car ownership journeys such as an in-house financing solution warranty options and Singapore’s first on-demand roadside recovery platform. The company was founded in 2015 and is headquartered in Singapore.

Panmnesia

Series A in 2024
Panmnesia is a Korean chip startup. It is focused on developing intellectual property around a technology, which allows big data center operators to pool devices such as AI accelerator chips, processors, and memory.

Boston Materials

Series A in 2024
Boston Materials, Inc. is a manufacturer of advanced composite materials, specializing in 3D reinforced carbon fiber pre-pregs. Founded in 2016 and based in Bedford, Massachusetts, the company utilizes patented Z-axis Fiber technology, which incorporates vertically aligned carbon fibers to enhance energy transfer properties. Its product line includes Carbon Supercomposite, a magnetically assembled carbon fiber pre-preg, which finds applications across various sectors such as aerospace, automotive, marine, wind energy, and sports equipment. Boston Materials' advanced materials aim to improve thermal, electrical, and mechanical properties, offering a roll-to-roll manufacturing process with in-line quality control and an annual production capacity of one million square meters. These innovations enable industries like semiconductors and electrified vehicles to achieve greater efficiency, reliability, and weight reduction while addressing critical challenges in durability and performance.

Inventera Pharmaceuticals

Series C in 2024
Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.

LESSENGERS

Series C in 2024
LESSENGERS specializes in optical interconnect solutions by utilizing polymer wires for optical waveguides in three-dimensional space. The company manufactures innovative optical wiring products designed to connect physical environments to digital platforms. Its offerings facilitate direct optical coupling without the need for lens optics, making them suitable for data center applications. By employing transparent polymer wires, LESSENGERS provides effective solutions for optical communication devices, including optical transceiver modules and photonics devices. This enables businesses to source reliable wiring for their communication products, thereby enhancing network connectivity for users.

Mediwhale

Series A in 2024
Mediwhale is a health diagnostics company that focuses on leveraging artificial intelligence to enhance the prevention of cardiovascular and kidney diseases. It operates a unique AI screening platform that assesses metabolic risks and diagnoses eye diseases through non-invasive retinal scans. The platform comprises several components, including RetiCVD for cardiovascular disease risk assessment, which utilizes coronary artery calcium scores to predict risks based on established guidelines. RetiCKD offers a chronic kidney disease risk assessment with improved predictive capabilities compared to traditional methods. Additionally, RetiEYE identifies common age-related eye diseases like diabetic retinopathy and glaucoma at their referable stages. Mediwhale's retinal-based systemic biomarkers have been clinically validated and are recognized in the medical community, supported by publications in reputable journals. Through its innovative approach, Mediwhale aims to establish a sustainable healthcare model that emphasizes early detection and intervention.

Unastella

Series A in 2024
Unastella operates its own launch vehicles to provide human space travel platform services.

Fitogether

Venture Round in 2024
Fitogether focuses on football data analysis and has developed a wearable electronic performance tracking system tailored for elite football leagues, teams, and players. This device facilitates the acquisition of player data and fitness management, enabling the monitoring of players' readiness and supporting periodization. Additionally, it offers performance evaluation metrics, including endurance and tactical analysis, through a cloud-based platform. This technology empowers players and coaches to assess the collected data effectively and manage player workload, enhancing overall performance and strategic decision-making in the sport.

iTruck

Series A in 2024
iTruck is a transportation application that operates a marketplace for the trading of used trucks, specifically catering to commercial purposes. The platform provides access to used heavy motor vehicles, commercial license plates, and various integrated spare parts essential for operational needs. By facilitating these transactions, iTruck enables clients to reduce costs and enhance operational efficiency in their trucking activities.

Beyond Technology Engineering

Venture Round in 2024
Beyond Technology Engineering is an energy company that provides carbon-neutral energy recycling solutions.

SSEM

Series B in 2024
SSEM is a developer of a tax management application aimed at assisting sole proprietors in managing their tax obligations. The app simplifies the process of calculating and reporting global income tax and value-added tax, making it easier for users to handle their tax responsibilities. By providing an efficient solution for tax filing, SSEM enables clients to focus on their core business activities without the added stress of navigating complex tax regulations.

Space Lintech

Series A in 2024
Space Lintech provides novel medical research, development, and manufacture in the microgravity environment of satellites and space stations.

AGL

Series B in 2024
AGL is a golf technology company that focuses on connecting golf courses through its software-as-a-service (SaaS) platform. This platform facilitates real-time tee-time bookings, thereby increasing convenience for golfers and driving digital innovation within the golf industry. AGL offers integrated solutions that include a Global Distribution System (GDS), payment processing, and enterprise resource planning (ERP) tailored for both domestic and international golf courses. With partnerships established with over 1,000 golf courses across more than 30 countries, AGL provides cloud-based information technology solutions that enhance the management of golf facilities. Its user-friendly interface minimizes the need for face-to-face interactions and supports wireless payment options, ultimately helping golf clubs to boost their revenues while improving the overall golfing experience for players.

AGL

Series B in 2024
AGL is a golf technology company that focuses on connecting golf courses through its software-as-a-service (SaaS) platform. This platform facilitates real-time tee-time bookings, thereby increasing convenience for golfers and driving digital innovation within the golf industry. AGL offers integrated solutions that include a Global Distribution System (GDS), payment processing, and enterprise resource planning (ERP) tailored for both domestic and international golf courses. With partnerships established with over 1,000 golf courses across more than 30 countries, AGL provides cloud-based information technology solutions that enhance the management of golf facilities. Its user-friendly interface minimizes the need for face-to-face interactions and supports wireless payment options, ultimately helping golf clubs to boost their revenues while improving the overall golfing experience for players.

BIGPICTURE

Series C in 2024
BIGPICTURE is a developer of educational software focused on the esports industry, aimed at gamers aspiring to become professionals. The company produces informative videos, including game stories and documentaries, to enhance the knowledge and skills of its users. In addition to educational content, BIGPICTURE manages esports teams and organizes online tournaments in collaboration with major gaming companies. This approach creates a comprehensive platform for gamers, providing both online and offline spaces for engagement and learning. Through its various initiatives, BIGPICTURE seeks to improve the overall esports experience for players and enthusiasts alike.

Tilda

Seed Round in 2024
Tilda is a machine learning platform that offers strategies for profit maximisation and risk minimization.

HeyDealer

Venture Round in 2024
HeyDealer is a price comparison platform for used cars.

ELROILAB

Series A in 2024
ELROILAB is a company specializing in artificial intelligence and quality assurance within the food and beverage industry. The company has developed an advanced hyperspectral imaging solution that detects foreign objects and contaminants in food materials, enhancing food safety and quality. This innovative technology allows for the identification of hard-to-detect contaminants that conventional methods may overlook, providing clients with effective quality control measures. ELROILAB's Spectral AI product plays a central role in its operations, supporting the company's commitment to ensuring the integrity of food products.

Novorex

Series A in 2023
Novorex focuses on developing small-molecule drugs aimed at treating oncology and neurology diseases. The company employs advanced technologies, including artificial intelligence, to enhance drug development processes. By integrating biophysical analysis with in vitro and in vivo assays, Novorex aims to improve the efficacy of its new treatments, ultimately providing patients with innovative solutions for cancer and central nervous system disorders.

Mezoo

Series B in 2023
Mezoo is a medical device manufacturing company focused on developing biomedical sensor technology aimed at enhancing human health through accurate diagnoses. The company has created a compact, patch-type electrocardiogram that can be affixed to a patient’s chest. This device monitors heart activity in real-time, allowing physicians to effectively manage and prevent heart disease. By providing essential health data, Mezoo's technology supports healthcare professionals in delivering timely and informed medical care.

Willog Co., Ltd.

Series B in 2023
Willog is an IoT-based logistics intelligence company that provides real-time visibility across the entire supply chain through its proprietary sensor devices and platform. This enables businesses to monitor various data points such as location, temperature, humidity, and shock during transportation, helping them track assets and ensure consistent product quality. Willog’s solution helps identify potential issues in the logistics process in advance and suggests solutions to save time and reduce costs. It is applicable across various industries and empowers customers to make data-driven decisions. • Sensor Devices (Hardware) To meet the needs of various customers and transportation sectors, Willog offers a lineup of monitoring devices tailored to each logistics segment. These devices collect logistics data throughout the transport process and securely transmit it to the monitoring software. • Monitoring Solution (Software) Willog provides software optimized for logistics processes in tandem with its sensor devices. The software intuitively displays logistics condition data such as temperature, humidity, shock, and light levels collected during transport, eliminating the need for time-consuming manual tasks like post-delivery data mapping. Based on the collected data, the system analyzes shipment history to detect potential issues in advance during transportation and storage, helping to predict and minimize loss or cost. Additionally, Willog’s proprietary data analysis methodology, Willog Connected Intelligence, generates specialized analytics reports for each logistics domain—delivering insights beyond basic data logs and alerts.

Charan

Seed Round in 2023
Charan is an operator of an e-commerce platform intended to sell second-hand fashion apparel.

Catch Table

Series D in 2023
Catch Table is a restaurant reservation management platform that offers online reservation services to customers. It allows users to filter restaurant options based on various criteria, including date, number of guests, cost, food category, and table type. The platform also provides additional information such as valet parking and corkage services, making it easier for customers to find the right dining experience. By enabling real-time reservations, Catch Table streamlines the process of booking tables in restaurants, facilitating a more efficient dining experience for both customers and restaurant operators.

MathFLAT

Series B in 2023
MathFLAT is a business-to-business mobile solution focused on enhancing mathematics education through an innovative ed-tech platform. The platform leverages artificial intelligence and big data analysis to optimize learning experiences for students while offering valuable resources for teachers. By identifying and suggesting tailored learning methods that address students' specific challenges, MathFLAT aims to improve educational outcomes and facilitate a more effective teaching process. This approach provides both students and educators with enhanced opportunities for success in mathematics education.

Freewheelin

Series B in 2023
Freewheelin is an edtech company developing AI-powered tools to personalize math education. Their platform offers services such as generating homework books, integrating with textbooks, managing student errors, and analyzing performance data to assist educators in course preparation. The company has curated a database of math resources in partnership with textbook publishers, ensuring teachers can use materials without copyright concerns.​

Wrtn Technologies

Series A in 2023
Wrtn Technologies develops an AI-based content creation platform that utilizes natural language processing to assist users in writing. Aimed at addressing the challenges associated with declining writing skills, the platform enables a collaborative approach where AI and humans work together. This innovative tool is designed particularly for Gen-Z, helping them enhance their creativity and productivity in writing. By leveraging advanced AI technology, Wrtn Technologies provides a unique solution that empowers clients to improve their writing capabilities and overcome obstacles in the creative process.

EverEx

Series A in 2023
EverEx is a software-based therapeutics company specialized on musculoskeletal disorders with an AI-enabled pose estimation.

Mediwhale

Series A in 2023
Mediwhale is a health diagnostics company that focuses on leveraging artificial intelligence to enhance the prevention of cardiovascular and kidney diseases. It operates a unique AI screening platform that assesses metabolic risks and diagnoses eye diseases through non-invasive retinal scans. The platform comprises several components, including RetiCVD for cardiovascular disease risk assessment, which utilizes coronary artery calcium scores to predict risks based on established guidelines. RetiCKD offers a chronic kidney disease risk assessment with improved predictive capabilities compared to traditional methods. Additionally, RetiEYE identifies common age-related eye diseases like diabetic retinopathy and glaucoma at their referable stages. Mediwhale's retinal-based systemic biomarkers have been clinically validated and are recognized in the medical community, supported by publications in reputable journals. Through its innovative approach, Mediwhale aims to establish a sustainable healthcare model that emphasizes early detection and intervention.

Illimis Therapeutics

Venture Round in 2023
Illimis Therapeutics is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases, particularly Alzheimer's disease. The company utilizes a chimeric fusion protein platform to create novel therapeutic options aimed at addressing the unmet medical needs in the treatment of degenerative brain conditions. By leveraging their specialized fusion protein technology, Illimis Therapeutics aims to provide new modalities for patients, enhancing the healthcare industry's ability to combat these challenging diseases.

Sooldamhwa

Series A in 2021
Sooldamhwa is a wine, beer and spirits company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.